A Review of Modern Computational Algorithms for Bayesian Optimal Design
暂无分享,去创建一个
Anthony N. Pettitt | Christopher C. Drovandi | James McGree | Elizabeth G. Ryan | Elizabeth G. Ryan | A. Pettitt | C. Drovandi | J. McGree
[1] I. Verdinelli. Miscellanea. A note on Bayesian design for the normal linear model with unknown error variance , 2000 .
[2] David Ríos Insua,et al. Robust Bayesian analysis , 2000 .
[3] Helga Wagner,et al. Likelihood-free Simulation-based Optimal Design , 2013 .
[4] X. Huan,et al. GRADIENT-BASED STOCHASTIC OPTIMIZATION METHODS IN BAYESIAN EXPERIMENTAL DESIGN , 2012, 1212.2228.
[5] James C. Spall,et al. AN OVERVIEW OF THE SIMULTANEOUS PERTURBATION METHOD FOR EFFICIENT OPTIMIZATION , 1998 .
[6] M. Degroot. Optimal Statistical Decisions , 1970 .
[7] W. J. Hill,et al. A Joint Design Criterion for the Dual Problem of Model Discrimination and Parameter Estimation , 1968 .
[8] Liam Paninski,et al. Asymptotic Theory of Information-Theoretic Experimental Design , 2005, Neural Computation.
[9] Peter A. J. Hilbers,et al. Optimal experiment design for model selection in biochemical networks , 2014, BMC Systems Biology.
[10] R. A. Leibler,et al. On Information and Sufficiency , 1951 .
[11] J. Geweke,et al. Bayesian Inference in Econometric Models Using Monte Carlo Integration , 1989 .
[12] W. J. Studden,et al. Theory Of Optimal Experiments , 1972 .
[13] H. Dette,et al. Response-adaptive dose-finding under model uncertainty , 2011, 1107.5883.
[14] David Lindley,et al. Bayesian Statistics, a Review , 1987 .
[15] Donald A. Berry,et al. Group sequential clinical trials: a classical evaluation of Bayesian decision-theoretic designs , 1994 .
[16] M. Wand,et al. Explaining Variational Approximations , 2010 .
[17] Michael P. H. Stumpf,et al. Maximizing the Information Content of Experiments in Systems Biology , 2013, PLoS Comput. Biol..
[18] J. Kiefer,et al. Optimum Designs in Regression Problems , 1959 .
[19] William J. Hill,et al. Discrimination Among Mechanistic Models , 1967 .
[20] N. Chopin. A sequential particle filter method for static models , 2002 .
[21] Samira Masoumi,et al. Sequential Markov Chain Monte Carlo (MCMC) model discrimination , 2013 .
[22] Teemu Pennanen,et al. An Adaptive Importance Sampling Technique , 2006 .
[23] Peter Müller,et al. A Bayesian Decision-Theoretic Dose-Finding Trial , 2006, Decis. Anal..
[24] Markus Hainy,et al. Likelihood-Free Simulation-Based Optimal Design: An Introduction , 2014 .
[25] Joseph B. Kadane,et al. A Gridding Method for Bayesian Sequential Decision Problems , 2003 .
[26] W. J. Studden,et al. Bayesian Optimal Designs for Linear Regression Models , 1991 .
[27] Emile H. L. Aarts,et al. Simulated Annealing: Theory and Applications , 1987, Mathematics and Its Applications.
[28] C. E. SHANNON,et al. A mathematical theory of communication , 1948, MOCO.
[29] Tuomas J. Lukka,et al. Bayesian adaptive estimation: The next dimension , 2006 .
[30] J. Bernardo. Expected Information as Expected Utility , 1979 .
[31] Jon Wakefield,et al. An Expected Loss Approach to the Design of Dosage Regimens Via Sampling‐Based Methods , 1994 .
[32] A. Pettitt,et al. Approximate Bayesian computation using indirect inference , 2011 .
[33] Chiara Tommasi,et al. Bayesian optimum designs for discriminating between models with any distribution , 2010, Comput. Stat. Data Anal..
[34] Y. Ho,et al. Perturbation analysis and optimization of queueing networks , 1982, 1982 21st IEEE Conference on Decision and Control.
[35] J. Kiefer. General Equivalence Theory for Optimum Designs (Approximate Theory) , 1974 .
[36] Robert J. Butera,et al. Sequential Optimal Design of Neurophysiology Experiments , 2009, Neural Computation.
[37] P. Müller,et al. Optimal Bayesian Design by Inhomogeneous Markov Chain Simulation , 2004 .
[38] J. Berger. Statistical Decision Theory and Bayesian Analysis , 1988 .
[39] Anthony N. Pettitt,et al. Towards Bayesian experimental design for nonlinear models that require a large number of sampling times , 2014, Comput. Stat. Data Anal..
[40] Peter Müller,et al. Sequential stopping for high-throughput experiments , 2013, Biostatistics.
[41] D Z D'Argenio,et al. Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments. , 1990, Mathematical biosciences.
[42] K. Chaloner. Optimal Bayesian Experimental Design for Linear Models , 1984 .
[43] Paul Gerhard Kinas,et al. Bayesian fishery stock assessment and decision making using adaptive importance sampling , 1996 .
[44] Dianpeng Wang,et al. Sequential Bayesian Design for Estimation of EDp , 2009, 2009 2nd International Conference on Biomedical Engineering and Informatics.
[45] H. Rue,et al. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations , 2009 .
[46] Peter J. Diggle,et al. Bayesian Geostatistical Design , 2006 .
[47] Joseph B. Kadane,et al. Optimal Experimental Design for Another's Analysis , 1993 .
[48] K. Chaloner,et al. Bayesian Experimental Design: A Review , 1995 .
[49] Eamonn J. Keogh,et al. Curse of Dimensionality , 2010, Encyclopedia of Machine Learning.
[50] Friedrich Pukelsheim,et al. Optimal weights for experimental designs on linearly independent support points , 1991 .
[51] Stephen J. Wright,et al. Numerical Optimization , 2018, Fundamental Statistical Inference.
[52] C. Bielza,et al. Decision Analysis by Augmented Probability Simulation , 1999 .
[53] Xun Huan,et al. Simulation-based optimal Bayesian experimental design for nonlinear systems , 2011, J. Comput. Phys..
[54] W. Näther. Optimum experimental designs , 1994 .
[55] J. L. Maryak,et al. P Global Random Optimization by Simultaneous Perturbation Stochastic Approximation , 2005 .
[56] Mark A. Pitt,et al. Adaptive Design Optimization: A Mutual Information-Based Approach to Model Discrimination in Cognitive Science , 2010, Neural Computation.
[57] E. Walter,et al. Robust experiment design via stochastic approximation , 1985 .
[58] Peter Müller,et al. Optimal Design via Curve Fitting of Monte Carlo Experiments , 1995 .
[59] James M. McGree,et al. A pseudo-marginal sequential Monte Carlo algorithm for random effects models in Bayesian sequential design , 2016, Stat. Comput..
[60] Drew Seils,et al. Optimal design , 2007 .
[61] C C Drovandi,et al. Estimation of Parameters for Macroparasite Population Evolution Using Approximate Bayesian Computation , 2011, Biometrics.
[62] W. J. Studden,et al. Compromise designs in heteroscedastic linear models , 1992 .
[63] H. Robbins. A Stochastic Approximation Method , 1951 .
[64] G. Gibson,et al. Optimal Observation Times in Experimental Epidemic Processes , 2008, Biometrics.
[65] J. Bernardo,et al. Simulation-Based Optimal Design , 1999 .
[66] Szu Hui Ng,et al. Design of follow‐up experiments for improving model discrimination and parameter estimation , 2004 .
[67] Christian P. Robert,et al. Bayesian-Optimal Design via Interacting Particle Systems , 2006 .
[68] K. Mengersen,et al. Adaptive Bayesian compound designs for dose finding studies , 2012 .
[69] Anthony N. Pettitt,et al. Simulation-based fully Bayesian experimental design for mixed effects models , 2015, Comput. Stat. Data Anal..
[70] H. Dette,et al. A Generalization of $D$- and $D_1$-Optimal Designs in Polynomial Regression , 1990 .
[71] Anthony C. Atkinson,et al. DT-optimum designs for model discrimination and parameter estimation , 2008 .
[72] T. Loredo. Bayesian Adaptive Exploration , 2004, astro-ph/0409386.
[73] Chiara Tommasi,et al. Optimal designs for both model discrimination and parameter estimation , 2008 .
[74] Anthony N Pettitt,et al. Bayesian Experimental Design for Models with Intractable Likelihoods , 2013, Biometrics.
[75] P. Bickel,et al. Curse-of-dimensionality revisited: Collapse of the particle filter in very large scale systems , 2008, 0805.3034.
[76] D. Lindley. The Choice of Variables in Multiple Regression , 1968 .
[77] Jason L. Loeppky,et al. Batch sequential designs for computer experiments , 2010 .
[78] David M. Borth,et al. A Total Entropy Criterion for the Dual Problem of Model Discrimination and Parameter Estimation , 1975 .
[79] Steven E. Rigdon,et al. Model-Oriented Design of Experiments , 1997, Technometrics.
[80] J L Palmer,et al. Bayesian optimal design in population models for haematologic data. , 1998, Statistics in medicine.
[81] J. López–Fidalgo,et al. An optimal experimental design criterion for discriminating between non‐normal models , 2007 .
[82] Peter Müller,et al. Screening designs for drug development. , 2007, Biostatistics.
[83] J. Zidek,et al. Designing and integrating composite networks for monitoring multivariate gaussian pollution fields , 2000 .
[84] J. Kiefer,et al. The Equivalence of Two Extremum Problems , 1960, Canadian Journal of Mathematics.
[85] P. Moral,et al. Sequential Monte Carlo samplers , 2002, cond-mat/0212648.
[86] A E Gelfand,et al. Approaches for optimal sequential decision analysis in clinical trials. , 1998, Biometrics.
[87] Peter D. H. Hill,et al. A Review of Experimental Design Procedures for Regression Model Discrimination , 1978 .
[88] K. Chaloner,et al. The Equivalence of Constrained and Weighted Designs in Multiple Objective Design Problems , 1996 .
[89] J Whitehead,et al. Bayesian decision procedures based on logistic regression models for dose-finding studies. , 1998, Journal of biopharmaceutical statistics.
[90] Heikki Haario,et al. Simulation-Based Optimal Design Using a Response Variance Criterion , 2012 .
[91] Michael Jackson,et al. Optimal Design of Experiments , 1994 .
[92] A. N. Pettitt,et al. A sequential Monte Carlo approach to derive sampling times and windows for population pharmacokinetic studies , 2012, Journal of Pharmacokinetics and Pharmacodynamics.
[93] John A. Nelder,et al. A Simplex Method for Function Minimization , 1965, Comput. J..
[94] J. Wolfowitz,et al. On a Theorem of Hoel and Levine on Extrapolation Designs , 1965 .
[95] Anthony N. Pettitt,et al. Fully Bayesian Experimental Design for Pharmacokinetic Studies , 2015, Entropy.
[96] D. Lindley. On a Measure of the Information Provided by an Experiment , 1956 .
[97] Peter Müller,et al. Optimal sampling times in population pharmacokinetic studies , 2001 .
[98] Kathryn Chaloner,et al. Bayesian Experimental Design for Nonlinear Mixed‐Effects Models with Application to HIV Dynamics , 2004, Biometrics.
[99] Raul Tempone,et al. Fast estimation of expected information gains for Bayesian experimental designs based on Laplace approximations , 2013 .
[100] D A Berry,et al. One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach. , 1988, Biometrics.
[101] Arnaud Doucet,et al. SMC Samplers for Bayesian Optimal Nonlinear Design , 2006, 2006 IEEE Nonlinear Statistical Signal Processing Workshop.
[102] Peter Müller,et al. Bayesian randomized clinical trials: A decision‐theoretic sequential design , 2004 .
[103] D. Balding,et al. Approximate Bayesian computation in population genetics. , 2002, Genetics.
[104] William F Rosenberger,et al. Sequential designs for ordinal phase I clinical trials. , 2009, Biometrical journal. Biometrische Zeitschrift.
[105] J. Kiefer. Optimum Experimental Designs , 1959 .
[106] J Whitehead,et al. Bayesian decision procedures for dose determining experiments. , 1995, Statistics in medicine.
[107] H. Rue,et al. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations , 2009 .
[108] James M. McGree,et al. Sequential Monte Carlo for Bayesian sequentially designed experiments for discrete data , 2013, Comput. Stat. Data Anal..
[109] Anthony N. Pettitt,et al. A Sequential Monte Carlo Algorithm to Incorporate Model Uncertainty in Bayesian Sequential Design , 2014 .
[110] K. J. Ryan,et al. Estimating Expected Information Gains for Experimental Designs With Application to the Random Fatigue-Limit Model , 2003 .
[111] Anthony N. Pettitt,et al. A sequential Monte Carlo approach to the sequential design for discriminating between rival continuous data models , 2012 .
[112] Sang Joon Kim,et al. A Mathematical Theory of Communication , 2006 .
[113] S B Duffull,et al. Optimal Design Criteria for Discrimination and Estimation in Nonlinear Models , 2009, Journal of biopharmaceutical statistics.